nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—ABCC1—Epirubicin—pancreatic cancer	0.0481	0.061	CbGbCtD
Indinavir—ABCC1—Irinotecan—pancreatic cancer	0.0468	0.0593	CbGbCtD
Indinavir—ABCC2—Tamoxifen—pancreatic cancer	0.0451	0.0572	CbGbCtD
Indinavir—SLCO1B1—Irinotecan—pancreatic cancer	0.0394	0.05	CbGbCtD
Indinavir—ABCC2—Irinotecan—pancreatic cancer	0.0346	0.0439	CbGbCtD
Indinavir—ABCC1—Docetaxel—pancreatic cancer	0.0343	0.0435	CbGbCtD
Indinavir—CYP3A7—Tamoxifen—pancreatic cancer	0.0301	0.0382	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0301	0.0382	CbGbCtD
Indinavir—ABCC1—Doxorubicin—pancreatic cancer	0.0256	0.0324	CbGbCtD
Indinavir—ABCC2—Docetaxel—pancreatic cancer	0.0254	0.0322	CbGbCtD
Indinavir—ABCC2—Sunitinib—pancreatic cancer	0.0253	0.032	CbGbCtD
Indinavir—CYP3A7—Irinotecan—pancreatic cancer	0.0231	0.0293	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0231	0.0293	CbGbCtD
Indinavir—CYP3A5—Tamoxifen—pancreatic cancer	0.0226	0.0286	CbGbCtD
Indinavir—CYP3A5—Erlotinib—pancreatic cancer	0.0192	0.0244	CbGbCtD
Indinavir—ABCC2—Doxorubicin—pancreatic cancer	0.0189	0.024	CbGbCtD
Indinavir—CYP2C19—Tamoxifen—pancreatic cancer	0.0182	0.0231	CbGbCtD
Indinavir—CYP3A5—Irinotecan—pancreatic cancer	0.0173	0.022	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0169	0.0215	CbGbCtD
Indinavir—CYP3A7—Docetaxel—pancreatic cancer	0.0169	0.0215	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0169	0.0214	CbGbCtD
Indinavir—CYP3A7—Sunitinib—pancreatic cancer	0.0169	0.0214	CbGbCtD
Indinavir—CYP2C9—Tamoxifen—pancreatic cancer	0.0151	0.0192	CbGbCtD
Indinavir—ABCB1—Tamoxifen—pancreatic cancer	0.0147	0.0186	CbGbCtD
Indinavir—CYP2D6—Tamoxifen—pancreatic cancer	0.0139	0.0176	CbGbCtD
Indinavir—CYP3A5—Docetaxel—pancreatic cancer	0.0127	0.0161	CbGbCtD
Indinavir—ABCB1—Gemcitabine—pancreatic cancer	0.0127	0.0161	CbGbCtD
Indinavir—CYP3A5—Sunitinib—pancreatic cancer	0.0127	0.016	CbGbCtD
Indinavir—ABCB1—Erlotinib—pancreatic cancer	0.0125	0.0159	CbGbCtD
Indinavir—CYP2D6—Erlotinib—pancreatic cancer	0.0118	0.0149	CbGbCtD
Indinavir—ABCB1—Irinotecan—pancreatic cancer	0.0113	0.0143	CbGbCtD
Indinavir—CYP2C9—Fluorouracil—pancreatic cancer	0.0112	0.0142	CbGbCtD
Indinavir—CYP3A4—Tamoxifen—pancreatic cancer	0.00881	0.0112	CbGbCtD
Indinavir—ABCB1—Docetaxel—pancreatic cancer	0.00827	0.0105	CbGbCtD
Indinavir—ABCB1—Sunitinib—pancreatic cancer	0.00823	0.0104	CbGbCtD
Indinavir—CYP3A4—Erlotinib—pancreatic cancer	0.00749	0.0095	CbGbCtD
Indinavir—CYP3A4—Irinotecan—pancreatic cancer	0.00676	0.00858	CbGbCtD
Indinavir—ABCB1—Doxorubicin—pancreatic cancer	0.00617	0.00782	CbGbCtD
Indinavir—CYP2D6—Doxorubicin—pancreatic cancer	0.00581	0.00737	CbGbCtD
Indinavir—CYP3A4—Docetaxel—pancreatic cancer	0.00496	0.00629	CbGbCtD
Indinavir—CYP3A4—Sunitinib—pancreatic cancer	0.00493	0.00626	CbGbCtD
Indinavir—ABCC2—bile duct—pancreatic cancer	0.00383	0.385	CbGeAlD
Indinavir—CYP3A4—Doxorubicin—pancreatic cancer	0.00369	0.00469	CbGbCtD
Indinavir—ABCC2—bile—pancreatic cancer	0.00295	0.296	CbGeAlD
Indinavir—SLCO1B1—digestive system—pancreatic cancer	0.000425	0.0426	CbGeAlD
Indinavir—CYP3A5—islet of Langerhans—pancreatic cancer	0.000363	0.0364	CbGeAlD
Indinavir—SLCO1A2—digestive system—pancreatic cancer	0.000346	0.0347	CbGeAlD
Indinavir—ABCC2—digestive system—pancreatic cancer	0.000322	0.0323	CbGeAlD
Indinavir—CYP2C19—digestive system—pancreatic cancer	0.000277	0.0277	CbGeAlD
Indinavir—CYP3A5—pancreas—pancreatic cancer	0.000255	0.0256	CbGeAlD
Indinavir—CYP3A5—digestive system—pancreatic cancer	0.000218	0.0219	CbGeAlD
Indinavir—CYP2C9—digestive system—pancreatic cancer	0.000214	0.0215	CbGeAlD
Indinavir—ABCB1—islet of Langerhans—pancreatic cancer	0.000193	0.0193	CbGeAlD
Indinavir—CYP3A4—digestive system—pancreatic cancer	0.000164	0.0164	CbGeAlD
Indinavir—CYP2D6—digestive system—pancreatic cancer	0.000161	0.0161	CbGeAlD
Indinavir—Vomiting—Sunitinib—pancreatic cancer	0.000136	0.000677	CcSEcCtD
Indinavir—Body temperature increased—Gemcitabine—pancreatic cancer	0.000136	0.000675	CcSEcCtD
Indinavir—ABCB1—pancreas—pancreatic cancer	0.000136	0.0136	CbGeAlD
Indinavir—Dysuria—Epirubicin—pancreatic cancer	0.000135	0.000672	CcSEcCtD
Indinavir—Rash—Sunitinib—pancreatic cancer	0.000135	0.000671	CcSEcCtD
Indinavir—Dermatitis—Sunitinib—pancreatic cancer	0.000135	0.00067	CcSEcCtD
Indinavir—Abdominal distension—Doxorubicin—pancreatic cancer	0.000135	0.000669	CcSEcCtD
Indinavir—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000135	0.000668	CcSEcCtD
Indinavir—Urticaria—Fluorouracil—pancreatic cancer	0.000134	0.000667	CcSEcCtD
Indinavir—Headache—Sunitinib—pancreatic cancer	0.000134	0.000667	CcSEcCtD
Indinavir—Syncope—Docetaxel—pancreatic cancer	0.000134	0.000666	CcSEcCtD
Indinavir—Pollakiuria—Epirubicin—pancreatic cancer	0.000134	0.000664	CcSEcCtD
Indinavir—Body temperature increased—Fluorouracil—pancreatic cancer	0.000134	0.000664	CcSEcCtD
Indinavir—Palpitations—Docetaxel—pancreatic cancer	0.000132	0.000656	CcSEcCtD
Indinavir—Weight increased—Epirubicin—pancreatic cancer	0.000132	0.000654	CcSEcCtD
Indinavir—Loss of consciousness—Docetaxel—pancreatic cancer	0.000132	0.000653	CcSEcCtD
Indinavir—Pancreatitis—Doxorubicin—pancreatic cancer	0.000131	0.000652	CcSEcCtD
Indinavir—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000131	0.000648	CcSEcCtD
Indinavir—Cough—Docetaxel—pancreatic cancer	0.000131	0.000648	CcSEcCtD
Indinavir—Angina pectoris—Doxorubicin—pancreatic cancer	0.000131	0.000648	CcSEcCtD
Indinavir—Hypersensitivity—Irinotecan—pancreatic cancer	0.00013	0.000646	CcSEcCtD
Indinavir—Pneumonia—Epirubicin—pancreatic cancer	0.00013	0.000645	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000128	0.000635	CcSEcCtD
Indinavir—Arthralgia—Docetaxel—pancreatic cancer	0.000127	0.000632	CcSEcCtD
Indinavir—Chest pain—Docetaxel—pancreatic cancer	0.000127	0.000632	CcSEcCtD
Indinavir—Myalgia—Docetaxel—pancreatic cancer	0.000127	0.000632	CcSEcCtD
Indinavir—Nausea—Sunitinib—pancreatic cancer	0.000127	0.000632	CcSEcCtD
Indinavir—Renal failure—Epirubicin—pancreatic cancer	0.000127	0.00063	CcSEcCtD
Indinavir—Asthenia—Irinotecan—pancreatic cancer	0.000127	0.000629	CcSEcCtD
Indinavir—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000127	0.000628	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000127	0.000628	CcSEcCtD
Indinavir—Jaundice—Epirubicin—pancreatic cancer	0.000126	0.000625	CcSEcCtD
Indinavir—Urinary tract infection—Epirubicin—pancreatic cancer	0.000126	0.000623	CcSEcCtD
Indinavir—Dysuria—Doxorubicin—pancreatic cancer	0.000125	0.000622	CcSEcCtD
Indinavir—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000125	0.000619	CcSEcCtD
Indinavir—Dry mouth—Docetaxel—pancreatic cancer	0.000125	0.000618	CcSEcCtD
Indinavir—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000125	0.000618	CcSEcCtD
Indinavir—Sweating—Epirubicin—pancreatic cancer	0.000124	0.000614	CcSEcCtD
Indinavir—Pollakiuria—Doxorubicin—pancreatic cancer	0.000124	0.000614	CcSEcCtD
Indinavir—Asthenia—Gemcitabine—pancreatic cancer	0.000123	0.000613	CcSEcCtD
Indinavir—Haematuria—Epirubicin—pancreatic cancer	0.000123	0.000611	CcSEcCtD
Indinavir—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000122	0.000606	CcSEcCtD
Indinavir—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000122	0.000606	CcSEcCtD
Indinavir—Oedema—Docetaxel—pancreatic cancer	0.000122	0.000606	CcSEcCtD
Indinavir—Weight increased—Doxorubicin—pancreatic cancer	0.000122	0.000605	CcSEcCtD
Indinavir—Pruritus—Gemcitabine—pancreatic cancer	0.000122	0.000604	CcSEcCtD
Indinavir—Sinusitis—Epirubicin—pancreatic cancer	0.000121	0.000601	CcSEcCtD
Indinavir—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000121	0.0006	CcSEcCtD
Indinavir—Diarrhoea—Irinotecan—pancreatic cancer	0.000121	0.0006	CcSEcCtD
Indinavir—Pneumonia—Doxorubicin—pancreatic cancer	0.00012	0.000596	CcSEcCtD
Indinavir—Shock—Docetaxel—pancreatic cancer	0.00012	0.000596	CcSEcCtD
Indinavir—Nervous system disorder—Docetaxel—pancreatic cancer	0.00012	0.000594	CcSEcCtD
Indinavir—Pruritus—Fluorouracil—pancreatic cancer	0.00012	0.000594	CcSEcCtD
Indinavir—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00012	0.000593	CcSEcCtD
Indinavir—Skin disorder—Docetaxel—pancreatic cancer	0.000119	0.000589	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000118	0.000588	CcSEcCtD
Indinavir—Diarrhoea—Gemcitabine—pancreatic cancer	0.000118	0.000584	CcSEcCtD
Indinavir—Renal failure—Doxorubicin—pancreatic cancer	0.000117	0.000583	CcSEcCtD
Indinavir—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000117	0.000581	CcSEcCtD
Indinavir—Dizziness—Irinotecan—pancreatic cancer	0.000117	0.00058	CcSEcCtD
Indinavir—Haemoglobin—Epirubicin—pancreatic cancer	0.000117	0.000578	CcSEcCtD
Indinavir—Jaundice—Doxorubicin—pancreatic cancer	0.000116	0.000578	CcSEcCtD
Indinavir—Anorexia—Docetaxel—pancreatic cancer	0.000116	0.000578	CcSEcCtD
Indinavir—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000116	0.000576	CcSEcCtD
Indinavir—Haemorrhage—Epirubicin—pancreatic cancer	0.000116	0.000575	CcSEcCtD
Indinavir—Hepatitis—Epirubicin—pancreatic cancer	0.000116	0.000575	CcSEcCtD
Indinavir—ABCB1—digestive system—pancreatic cancer	0.000116	0.0116	CbGeAlD
Indinavir—Diarrhoea—Fluorouracil—pancreatic cancer	0.000116	0.000574	CcSEcCtD
Indinavir—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000115	0.000572	CcSEcCtD
Indinavir—Pharyngitis—Epirubicin—pancreatic cancer	0.000115	0.000571	CcSEcCtD
Indinavir—Sweating—Doxorubicin—pancreatic cancer	0.000115	0.000568	CcSEcCtD
Indinavir—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000114	0.000568	CcSEcCtD
Indinavir—Haematuria—Doxorubicin—pancreatic cancer	0.000114	0.000565	CcSEcCtD
Indinavir—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000114	0.000565	CcSEcCtD
Indinavir—Urethral disorder—Epirubicin—pancreatic cancer	0.000114	0.000564	CcSEcCtD
Indinavir—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000113	0.000561	CcSEcCtD
Indinavir—Vomiting—Irinotecan—pancreatic cancer	0.000112	0.000557	CcSEcCtD
Indinavir—Sinusitis—Doxorubicin—pancreatic cancer	0.000112	0.000556	CcSEcCtD
Indinavir—Dizziness—Fluorouracil—pancreatic cancer	0.000112	0.000555	CcSEcCtD
Indinavir—Rash—Irinotecan—pancreatic cancer	0.000111	0.000553	CcSEcCtD
Indinavir—Dermatitis—Irinotecan—pancreatic cancer	0.000111	0.000552	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000111	0.000552	CcSEcCtD
Indinavir—Headache—Irinotecan—pancreatic cancer	0.000111	0.000549	CcSEcCtD
Indinavir—Insomnia—Docetaxel—pancreatic cancer	0.00011	0.000548	CcSEcCtD
Indinavir—Paraesthesia—Docetaxel—pancreatic cancer	0.00011	0.000544	CcSEcCtD
Indinavir—Erythema multiforme—Epirubicin—pancreatic cancer	0.00011	0.000544	CcSEcCtD
Indinavir—Vomiting—Gemcitabine—pancreatic cancer	0.000109	0.000543	CcSEcCtD
Indinavir—Dyspnoea—Docetaxel—pancreatic cancer	0.000109	0.00054	CcSEcCtD
Indinavir—Somnolence—Docetaxel—pancreatic cancer	0.000109	0.000539	CcSEcCtD
Indinavir—Rash—Gemcitabine—pancreatic cancer	0.000108	0.000538	CcSEcCtD
Indinavir—Dermatitis—Gemcitabine—pancreatic cancer	0.000108	0.000538	CcSEcCtD
Indinavir—Haemoglobin—Doxorubicin—pancreatic cancer	0.000108	0.000535	CcSEcCtD
Indinavir—Headache—Gemcitabine—pancreatic cancer	0.000108	0.000535	CcSEcCtD
Indinavir—Flushing—Epirubicin—pancreatic cancer	0.000108	0.000534	CcSEcCtD
Indinavir—Vomiting—Fluorouracil—pancreatic cancer	0.000108	0.000534	CcSEcCtD
Indinavir—Dyspepsia—Docetaxel—pancreatic cancer	0.000107	0.000533	CcSEcCtD
Indinavir—Hepatitis—Doxorubicin—pancreatic cancer	0.000107	0.000532	CcSEcCtD
Indinavir—Haemorrhage—Doxorubicin—pancreatic cancer	0.000107	0.000532	CcSEcCtD
Indinavir—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000107	0.00053	CcSEcCtD
Indinavir—Rash—Fluorouracil—pancreatic cancer	0.000107	0.000529	CcSEcCtD
Indinavir—Dermatitis—Fluorouracil—pancreatic cancer	0.000107	0.000529	CcSEcCtD
Indinavir—Pharyngitis—Doxorubicin—pancreatic cancer	0.000106	0.000528	CcSEcCtD
Indinavir—Decreased appetite—Docetaxel—pancreatic cancer	0.000106	0.000527	CcSEcCtD
Indinavir—Headache—Fluorouracil—pancreatic cancer	0.000106	0.000526	CcSEcCtD
Indinavir—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000106	0.000526	CcSEcCtD
Indinavir—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000105	0.000523	CcSEcCtD
Indinavir—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000105	0.000523	CcSEcCtD
Indinavir—Fatigue—Docetaxel—pancreatic cancer	0.000105	0.000522	CcSEcCtD
Indinavir—Urethral disorder—Doxorubicin—pancreatic cancer	0.000105	0.000522	CcSEcCtD
Indinavir—Nausea—Irinotecan—pancreatic cancer	0.000105	0.000521	CcSEcCtD
Indinavir—Immune system disorder—Epirubicin—pancreatic cancer	0.000105	0.00052	CcSEcCtD
Indinavir—Pain—Docetaxel—pancreatic cancer	0.000104	0.000518	CcSEcCtD
Indinavir—Constipation—Docetaxel—pancreatic cancer	0.000104	0.000518	CcSEcCtD
Indinavir—Chills—Epirubicin—pancreatic cancer	0.000104	0.000516	CcSEcCtD
Indinavir—Alopecia—Epirubicin—pancreatic cancer	0.000102	0.000508	CcSEcCtD
Indinavir—Nausea—Gemcitabine—pancreatic cancer	0.000102	0.000507	CcSEcCtD
Indinavir—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000101	0.000503	CcSEcCtD
Indinavir—Malnutrition—Epirubicin—pancreatic cancer	0.000101	0.000501	CcSEcCtD
Indinavir—Feeling abnormal—Docetaxel—pancreatic cancer	0.000101	0.000499	CcSEcCtD
Indinavir—Nausea—Fluorouracil—pancreatic cancer	0.0001	0.000499	CcSEcCtD
Indinavir—Gastrointestinal pain—Docetaxel—pancreatic cancer	9.99e-05	0.000496	CcSEcCtD
Indinavir—Flushing—Doxorubicin—pancreatic cancer	9.96e-05	0.000494	CcSEcCtD
Indinavir—Flatulence—Epirubicin—pancreatic cancer	9.94e-05	0.000493	CcSEcCtD
Indinavir—Tension—Epirubicin—pancreatic cancer	9.9e-05	0.000491	CcSEcCtD
Indinavir—Dysgeusia—Epirubicin—pancreatic cancer	9.88e-05	0.00049	CcSEcCtD
Indinavir—Nervousness—Epirubicin—pancreatic cancer	9.8e-05	0.000486	CcSEcCtD
Indinavir—Back pain—Epirubicin—pancreatic cancer	9.76e-05	0.000484	CcSEcCtD
Indinavir—Muscle spasms—Epirubicin—pancreatic cancer	9.7e-05	0.000481	CcSEcCtD
Indinavir—Immune system disorder—Doxorubicin—pancreatic cancer	9.69e-05	0.000481	CcSEcCtD
Indinavir—Abdominal pain—Docetaxel—pancreatic cancer	9.65e-05	0.000479	CcSEcCtD
Indinavir—Body temperature increased—Docetaxel—pancreatic cancer	9.65e-05	0.000479	CcSEcCtD
Indinavir—Chills—Doxorubicin—pancreatic cancer	9.63e-05	0.000478	CcSEcCtD
Indinavir—Vision blurred—Epirubicin—pancreatic cancer	9.51e-05	0.000472	CcSEcCtD
Indinavir—Alopecia—Doxorubicin—pancreatic cancer	9.48e-05	0.00047	CcSEcCtD
Indinavir—Ill-defined disorder—Epirubicin—pancreatic cancer	9.36e-05	0.000465	CcSEcCtD
Indinavir—Malnutrition—Doxorubicin—pancreatic cancer	9.34e-05	0.000463	CcSEcCtD
Indinavir—Anaemia—Epirubicin—pancreatic cancer	9.33e-05	0.000463	CcSEcCtD
Indinavir—Agitation—Epirubicin—pancreatic cancer	9.27e-05	0.00046	CcSEcCtD
Indinavir—Flatulence—Doxorubicin—pancreatic cancer	9.2e-05	0.000457	CcSEcCtD
Indinavir—Tension—Doxorubicin—pancreatic cancer	9.16e-05	0.000455	CcSEcCtD
Indinavir—Dysgeusia—Doxorubicin—pancreatic cancer	9.14e-05	0.000454	CcSEcCtD
Indinavir—Malaise—Epirubicin—pancreatic cancer	9.1e-05	0.000452	CcSEcCtD
Indinavir—Nervousness—Doxorubicin—pancreatic cancer	9.07e-05	0.00045	CcSEcCtD
Indinavir—Vertigo—Epirubicin—pancreatic cancer	9.07e-05	0.00045	CcSEcCtD
Indinavir—Syncope—Epirubicin—pancreatic cancer	9.05e-05	0.000449	CcSEcCtD
Indinavir—Back pain—Doxorubicin—pancreatic cancer	9.03e-05	0.000448	CcSEcCtD
Indinavir—Hypersensitivity—Docetaxel—pancreatic cancer	9e-05	0.000446	CcSEcCtD
Indinavir—Muscle spasms—Doxorubicin—pancreatic cancer	8.98e-05	0.000446	CcSEcCtD
Indinavir—Palpitations—Epirubicin—pancreatic cancer	8.92e-05	0.000443	CcSEcCtD
Indinavir—Loss of consciousness—Epirubicin—pancreatic cancer	8.87e-05	0.00044	CcSEcCtD
Indinavir—Cough—Epirubicin—pancreatic cancer	8.81e-05	0.000437	CcSEcCtD
Indinavir—Vision blurred—Doxorubicin—pancreatic cancer	8.8e-05	0.000437	CcSEcCtD
Indinavir—Asthenia—Docetaxel—pancreatic cancer	8.76e-05	0.000435	CcSEcCtD
Indinavir—Ill-defined disorder—Doxorubicin—pancreatic cancer	8.66e-05	0.00043	CcSEcCtD
Indinavir—Pruritus—Docetaxel—pancreatic cancer	8.64e-05	0.000429	CcSEcCtD
Indinavir—Anaemia—Doxorubicin—pancreatic cancer	8.63e-05	0.000428	CcSEcCtD
Indinavir—Chest pain—Epirubicin—pancreatic cancer	8.59e-05	0.000426	CcSEcCtD
Indinavir—Arthralgia—Epirubicin—pancreatic cancer	8.59e-05	0.000426	CcSEcCtD
Indinavir—Myalgia—Epirubicin—pancreatic cancer	8.59e-05	0.000426	CcSEcCtD
Indinavir—Agitation—Doxorubicin—pancreatic cancer	8.58e-05	0.000426	CcSEcCtD
Indinavir—Anxiety—Epirubicin—pancreatic cancer	8.56e-05	0.000425	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	8.53e-05	0.000423	CcSEcCtD
Indinavir—Discomfort—Epirubicin—pancreatic cancer	8.49e-05	0.000421	CcSEcCtD
Indinavir—Malaise—Doxorubicin—pancreatic cancer	8.42e-05	0.000418	CcSEcCtD
Indinavir—Dry mouth—Epirubicin—pancreatic cancer	8.4e-05	0.000417	CcSEcCtD
Indinavir—Vertigo—Doxorubicin—pancreatic cancer	8.39e-05	0.000416	CcSEcCtD
Indinavir—Syncope—Doxorubicin—pancreatic cancer	8.37e-05	0.000416	CcSEcCtD
Indinavir—Diarrhoea—Docetaxel—pancreatic cancer	8.36e-05	0.000415	CcSEcCtD
Indinavir—Palpitations—Doxorubicin—pancreatic cancer	8.25e-05	0.000409	CcSEcCtD
Indinavir—Anaphylactic shock—Epirubicin—pancreatic cancer	8.24e-05	0.000409	CcSEcCtD
Indinavir—Oedema—Epirubicin—pancreatic cancer	8.24e-05	0.000409	CcSEcCtD
Indinavir—Loss of consciousness—Doxorubicin—pancreatic cancer	8.21e-05	0.000407	CcSEcCtD
Indinavir—Cough—Doxorubicin—pancreatic cancer	8.15e-05	0.000404	CcSEcCtD
Indinavir—Shock—Epirubicin—pancreatic cancer	8.1e-05	0.000402	CcSEcCtD
Indinavir—Nervous system disorder—Epirubicin—pancreatic cancer	8.08e-05	0.000401	CcSEcCtD
Indinavir—Dizziness—Docetaxel—pancreatic cancer	8.08e-05	0.000401	CcSEcCtD
Indinavir—Thrombocytopenia—Epirubicin—pancreatic cancer	8.06e-05	0.0004	CcSEcCtD
Indinavir—Skin disorder—Epirubicin—pancreatic cancer	8e-05	0.000397	CcSEcCtD
Indinavir—Hyperhidrosis—Epirubicin—pancreatic cancer	7.96e-05	0.000395	CcSEcCtD
Indinavir—Myalgia—Doxorubicin—pancreatic cancer	7.95e-05	0.000394	CcSEcCtD
Indinavir—Arthralgia—Doxorubicin—pancreatic cancer	7.95e-05	0.000394	CcSEcCtD
Indinavir—Chest pain—Doxorubicin—pancreatic cancer	7.95e-05	0.000394	CcSEcCtD
Indinavir—Anxiety—Doxorubicin—pancreatic cancer	7.92e-05	0.000393	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	7.9e-05	0.000392	CcSEcCtD
Indinavir—Discomfort—Doxorubicin—pancreatic cancer	7.85e-05	0.00039	CcSEcCtD
Indinavir—Anorexia—Epirubicin—pancreatic cancer	7.85e-05	0.00039	CcSEcCtD
Indinavir—Dry mouth—Doxorubicin—pancreatic cancer	7.78e-05	0.000386	CcSEcCtD
Indinavir—Vomiting—Docetaxel—pancreatic cancer	7.76e-05	0.000385	CcSEcCtD
Indinavir—Rash—Docetaxel—pancreatic cancer	7.7e-05	0.000382	CcSEcCtD
Indinavir—Dermatitis—Docetaxel—pancreatic cancer	7.69e-05	0.000382	CcSEcCtD
Indinavir—Headache—Docetaxel—pancreatic cancer	7.65e-05	0.00038	CcSEcCtD
Indinavir—Anaphylactic shock—Doxorubicin—pancreatic cancer	7.62e-05	0.000378	CcSEcCtD
Indinavir—Oedema—Doxorubicin—pancreatic cancer	7.62e-05	0.000378	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.5e-05	0.000372	CcSEcCtD
Indinavir—Shock—Doxorubicin—pancreatic cancer	7.5e-05	0.000372	CcSEcCtD
Indinavir—Nervous system disorder—Doxorubicin—pancreatic cancer	7.47e-05	0.000371	CcSEcCtD
Indinavir—Thrombocytopenia—Doxorubicin—pancreatic cancer	7.46e-05	0.00037	CcSEcCtD
Indinavir—Insomnia—Epirubicin—pancreatic cancer	7.45e-05	0.00037	CcSEcCtD
Indinavir—Skin disorder—Doxorubicin—pancreatic cancer	7.4e-05	0.000367	CcSEcCtD
Indinavir—Paraesthesia—Epirubicin—pancreatic cancer	7.4e-05	0.000367	CcSEcCtD
Indinavir—Hyperhidrosis—Doxorubicin—pancreatic cancer	7.37e-05	0.000366	CcSEcCtD
Indinavir—Dyspnoea—Epirubicin—pancreatic cancer	7.34e-05	0.000364	CcSEcCtD
Indinavir—Somnolence—Epirubicin—pancreatic cancer	7.32e-05	0.000363	CcSEcCtD
Indinavir—Anorexia—Doxorubicin—pancreatic cancer	7.26e-05	0.00036	CcSEcCtD
Indinavir—Nausea—Docetaxel—pancreatic cancer	7.25e-05	0.00036	CcSEcCtD
Indinavir—Dyspepsia—Epirubicin—pancreatic cancer	7.25e-05	0.00036	CcSEcCtD
Indinavir—Decreased appetite—Epirubicin—pancreatic cancer	7.16e-05	0.000355	CcSEcCtD
Indinavir—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.11e-05	0.000353	CcSEcCtD
Indinavir—Fatigue—Epirubicin—pancreatic cancer	7.1e-05	0.000352	CcSEcCtD
Indinavir—Constipation—Epirubicin—pancreatic cancer	7.04e-05	0.00035	CcSEcCtD
Indinavir—Pain—Epirubicin—pancreatic cancer	7.04e-05	0.00035	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	6.94e-05	0.000345	CcSEcCtD
Indinavir—Insomnia—Doxorubicin—pancreatic cancer	6.89e-05	0.000342	CcSEcCtD
Indinavir—Paraesthesia—Doxorubicin—pancreatic cancer	6.84e-05	0.00034	CcSEcCtD
Indinavir—Dyspnoea—Doxorubicin—pancreatic cancer	6.79e-05	0.000337	CcSEcCtD
Indinavir—Feeling abnormal—Epirubicin—pancreatic cancer	6.79e-05	0.000337	CcSEcCtD
Indinavir—Somnolence—Doxorubicin—pancreatic cancer	6.78e-05	0.000336	CcSEcCtD
Indinavir—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.74e-05	0.000334	CcSEcCtD
Indinavir—Dyspepsia—Doxorubicin—pancreatic cancer	6.71e-05	0.000333	CcSEcCtD
Indinavir—Decreased appetite—Doxorubicin—pancreatic cancer	6.63e-05	0.000329	CcSEcCtD
Indinavir—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.58e-05	0.000326	CcSEcCtD
Indinavir—Fatigue—Doxorubicin—pancreatic cancer	6.57e-05	0.000326	CcSEcCtD
Indinavir—Urticaria—Epirubicin—pancreatic cancer	6.54e-05	0.000325	CcSEcCtD
Indinavir—Pain—Doxorubicin—pancreatic cancer	6.52e-05	0.000323	CcSEcCtD
Indinavir—Constipation—Doxorubicin—pancreatic cancer	6.52e-05	0.000323	CcSEcCtD
Indinavir—Body temperature increased—Epirubicin—pancreatic cancer	6.51e-05	0.000323	CcSEcCtD
Indinavir—Abdominal pain—Epirubicin—pancreatic cancer	6.51e-05	0.000323	CcSEcCtD
Indinavir—Feeling abnormal—Doxorubicin—pancreatic cancer	6.28e-05	0.000312	CcSEcCtD
Indinavir—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.23e-05	0.000309	CcSEcCtD
Indinavir—Hypersensitivity—Epirubicin—pancreatic cancer	6.07e-05	0.000301	CcSEcCtD
Indinavir—Urticaria—Doxorubicin—pancreatic cancer	6.05e-05	0.0003	CcSEcCtD
Indinavir—Body temperature increased—Doxorubicin—pancreatic cancer	6.02e-05	0.000299	CcSEcCtD
Indinavir—Abdominal pain—Doxorubicin—pancreatic cancer	6.02e-05	0.000299	CcSEcCtD
Indinavir—Asthenia—Epirubicin—pancreatic cancer	5.91e-05	0.000293	CcSEcCtD
Indinavir—Pruritus—Epirubicin—pancreatic cancer	5.83e-05	0.000289	CcSEcCtD
Indinavir—Diarrhoea—Epirubicin—pancreatic cancer	5.64e-05	0.00028	CcSEcCtD
Indinavir—Hypersensitivity—Doxorubicin—pancreatic cancer	5.61e-05	0.000279	CcSEcCtD
Indinavir—Asthenia—Doxorubicin—pancreatic cancer	5.47e-05	0.000271	CcSEcCtD
Indinavir—Dizziness—Epirubicin—pancreatic cancer	5.45e-05	0.00027	CcSEcCtD
Indinavir—Pruritus—Doxorubicin—pancreatic cancer	5.39e-05	0.000268	CcSEcCtD
Indinavir—Vomiting—Epirubicin—pancreatic cancer	5.24e-05	0.00026	CcSEcCtD
Indinavir—Diarrhoea—Doxorubicin—pancreatic cancer	5.21e-05	0.000259	CcSEcCtD
Indinavir—Rash—Epirubicin—pancreatic cancer	5.19e-05	0.000258	CcSEcCtD
Indinavir—Dermatitis—Epirubicin—pancreatic cancer	5.19e-05	0.000257	CcSEcCtD
Indinavir—Headache—Epirubicin—pancreatic cancer	5.16e-05	0.000256	CcSEcCtD
Indinavir—Dizziness—Doxorubicin—pancreatic cancer	5.04e-05	0.00025	CcSEcCtD
Indinavir—Nausea—Epirubicin—pancreatic cancer	4.89e-05	0.000243	CcSEcCtD
Indinavir—Vomiting—Doxorubicin—pancreatic cancer	4.85e-05	0.00024	CcSEcCtD
Indinavir—Rash—Doxorubicin—pancreatic cancer	4.81e-05	0.000238	CcSEcCtD
Indinavir—Dermatitis—Doxorubicin—pancreatic cancer	4.8e-05	0.000238	CcSEcCtD
Indinavir—Headache—Doxorubicin—pancreatic cancer	4.77e-05	0.000237	CcSEcCtD
Indinavir—Nausea—Doxorubicin—pancreatic cancer	4.53e-05	0.000225	CcSEcCtD
